MARK A SCHLOSSBERG Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MARK A SCHLOSSBERG.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MARK A SCHLOSSBERG. MARK A SCHLOSSBERG is SVP and General Counsel in IMPAX LABORATORIES INC ($IPXL) and Director in ImmunoCellular Therapeutics, Ltd. ($IMUC) and SVP - Legal & General Counsel in CYTOKINETICS INC ($CYTK).

Latest Insider Trading Transactions of MARK A SCHLOSSBERG

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CYTK, IMUC, IPXL

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 09 2021	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Payment of Exercise	F	19.19	4,150	79,639	50,850	55 K to 50.9 K (-7.55 %)
Mar 04 2021	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Option Exercise	A	19.42	34,871	677,195	34,871
Mar 04 2021	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Option Exercise	A	19.42	10,129	196,705	10,129
Mar 04 2021	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Grant	A	0.00	25,000	0	55,000	30 K to 55 K (+83.33 %)
Aug 21 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Option Exercise	M	7.03	10,000	70,300	35,244
Aug 21 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Sell	S	25.00	10,000	250,000	30,000	40 K to 30 K (-25.00 %)
Aug 21 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Buy	M	7.03	10,000	70,300	40,000	30 K to 40 K (+33.33 %)
Jul 30 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Option Exercise	M	7.03	10,000	70,300	45,244
Jul 30 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Sell	S	23.07	10,000	230,728	30,000	40 K to 30 K (-25.00 %)
Jul 30 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Buy	M	7.03	10,000	70,300	40,000	30 K to 40 K (+33.33 %)
Mar 09 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Option Exercise	A	14.40	50,393	725,659	50,393
Mar 09 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Option Exercise	A	14.40	9,607	138,341	9,607
Mar 09 2020	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Grant	A	0.00	30,000	0	30,000	0 to 30 K
Feb 04 2019	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Option Exercise	A	7.03	55,244	388,365	55,244
Feb 04 2019	CYTK	CYTOKINETICS INC	SCHLOSSBERG MARK A	SVP - Legal & Gener ...	Option Exercise	A	7.03	44,756	314,635	44,756
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	D	21.24	100,000	2,124,000	0
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	D	20.90	21,667	452,840	0
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	D	17.99	52,000	935,480	0
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	D	25.24	55,000	1,388,200	0
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	D	40.70	47,500	1,933,250	0
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	D	33.27	52,801	1,756,689	0
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	D	9.35	56,232	525,769	0
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Sell	D	0.00	18,135	0	0	18.1 K to 0 (-100.00 %)
May 08 2018	IPXL	Impax Laboratories ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Sell	D	0.00	50,116	0	0	50.1 K to 0 (-100.00 %)
Mar 05 2018	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	19.50	3,273	63,824	89,246	92.5 K to 89.2 K (-3.54 %)
Feb 27 2018	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	20.95	5,937	124,380	92,519	98.5 K to 92.5 K (-6.03 %)
May 16 2017	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	16.80	3,488	58,598	98,456	101.9 K to 98.5 K (-3.42 %)
May 16 2017	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	17.65	3,235	57,098	101,944	105.2 K to 101.9 K (-3.08 %)
Mar 06 2017	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	A	9.35	56,232	525,769	56,232
Mar 06 2017	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Grant	A	0.00	23,272	0	105,179	81.9 K to 105.2 K (+28.41 %)
Feb 27 2017	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	14.05	6,014	84,497	81,907	87.9 K to 81.9 K (-6.84 %)
Jun 21 2016	IMUC	ImmunoCellular The ...	SCHLOSSBERG MARK A	Director	Option Exercise	A	0.24	156,750	37,620	156,750
May 24 2016	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	32.12	1,095	35,171	87,921	89 K to 87.9 K (-1.23 %)
May 16 2016	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	29.18	2,330	67,989	89,016	91.3 K to 89 K (-2.55 %)
May 16 2016	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	29.18	2,163	63,116	91,346	93.5 K to 91.3 K (-2.31 %)
Mar 01 2016	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	A	33.27	52,801	1,756,689	52,801
Mar 01 2016	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Grant	A	0.00	21,852	0	93,509	71.7 K to 93.5 K (+30.50 %)
Mar 01 2016	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	33.27	1,931	64,244	71,657	73.6 K to 71.7 K (-2.62 %)
Sep 22 2015	IMUC	ImmunoCellular The ...	SCHLOSSBERG MARK A	Director	Option Exercise	A	0.47	40,000	18,800	40,000
Sep 14 2015	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Sell	S	43.30	7,457	322,888	73,588	81 K to 73.6 K (-9.20 %)
Aug 27 2015	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Sell	S	43.41	4,649	201,813	81,045	85.7 K to 81 K (-5.43 %)
Jul 09 2015	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	45.99	3,916	180,097	85,694	89.6 K to 85.7 K (-4.37 %)
May 26 2015	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	46.21	1,102	50,923	89,610	90.7 K to 89.6 K (-1.21 %)
May 19 2015	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	44.44	2,330	103,545	90,712	93 K to 90.7 K (-2.50 %)
May 19 2015	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	44.82	2,163	96,946	93,042	95.2 K to 93 K (-2.27 %)
Mar 12 2015	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	A	40.70	47,500	1,933,250	47,500
Mar 12 2015	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Grant	A	0.00	20,000	0	95,205	75.2 K to 95.2 K (+26.59 %)
Jul 16 2014	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	28.80	2,819	81,187	75,205	78 K to 75.2 K (-3.61 %)
May 28 2014	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	27.89	815	22,730	78,024	78.8 K to 78 K (-1.03 %)
May 16 2014	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	A	25.24	55,000	1,388,200	55,000
May 16 2014	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	25.56	2,330	59,555	78,839	81.2 K to 78.8 K (-2.87 %)
May 16 2014	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Grant	A	0.00	23,000	0	81,169	58.2 K to 81.2 K (+39.54 %)
Jul 09 2013	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	20.33	2,752	55,951	58,169	60.9 K to 58.2 K (-4.52 %)
May 28 2013	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	18.60	795	14,787	60,921	61.7 K to 60.9 K (-1.29 %)
May 16 2013	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	A	17.99	52,000	935,480	52,000
May 16 2013	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Grant	A	0.00	24,800	0	61,716	36.9 K to 61.7 K (+67.18 %)
Mar 14 2013	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Buy	P	16.73	1,000	16,728	36,916	35.9 K to 36.9 K (+2.78 %)
Jul 09 2012	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Payment of Exercise	F	20.25	2,751	55,708	35,916	38.7 K to 35.9 K (-7.11 %)
May 25 2012	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	A	20.90	21,667	452,840	21,667
May 25 2012	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Grant	A	0.00	8,667	0	38,667	30 K to 38.7 K (+28.89 %)
Jul 11 2011	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Option Exercise	A	21.24	100,000	2,124,000	100,000
Jul 11 2011	IPXL	IMPAX LABORATORIES ...	SCHLOSSBERG MARK A	SVP and General Cou ...	Grant	A	0.00	30,000	0	30,000	0 to 30 K

Page: 1